Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1 1

Status

Completed 10Terminated 3Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 8INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Adenoma 2Polyps 1Neoplasms 1Colonic Neoplasms 1Adenomatous Polyps 1

Interventions

pembrolizumab 183Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 53fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 39Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Colonoscopy × Clear all
NCT00486512 2020-09-03

Chemoprevention of Colorectal Adenomas

Colotech A/S

Phase 3 Terminated
350 enrolled

Adenoma, Adenomatous Polyps

NCT02926209 2019-07-16

Post Market Evaluation of Aer-O-Scope Visualization

GI View Ltd.

Phase NA Terminated
104 enrolled 5 charts

Adenoma, Neoplasms, Polyps

NCT02102412 2017-08-01

First in Man Aer-O-Scope

GI View Ltd.

Phase 1 Terminated
101 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡